Shai Attia

Graymatters Health develops self-neuromodulation therapies for mental health care. Graymatters Health is based in Haifa, Israel. The Israeli company is the first to develop a treatment based on digital biomarkers of brain-mechanism-specific activity associated with mental disorders. The company's flagship FDA-cleared product, Prism for PTSD, is an award-winning digital therapy that uses advanced statistical models to register fMRI data with an accessible and low-cost modality, EEG. The company's products use these biomarkers with an interactive simulation to help patients regain control over the relevant brain activity. Graymatters Health is collaborating with leading mental health institutions to evaluate Prism for additional mental disorders. The company was founded by Rani Cohen, Oded Kraft, Shai Attia, and Oded Kraft has been the CEO since incorporation.